Home > Insider Trading > Filing (0001415889-24-009034)

Filing Details

Accession Number:: 0001415889-24-009034
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-25 16:30:19
Reporting Period:: 2024-03-21

Accepted Time:: 2024-03-25 16:30:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082554	United Therapeutics Corp	UTHR	Pharmaceutical Preparations (2834)	521984749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1106578	A Martine Rothblatt	C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910	Chairperson & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-03-21	15,000	$129.49	15,130	No	4	M	Direct
Common Stock	Disposition	2024-03-21	1,353	$234.38	13,777	No	4	S	Direct
Common Stock	Disposition	2024-03-21	2,500	$235.58	11,277	No	4	S	Direct
Common Stock	Disposition	2024-03-21	8,650	$236.57	2,627	No	4	S	Direct
Common Stock	Disposition	2024-03-21	2,497	$237.38	130	No	4	S	Direct
Common Stock	Acquisiton	2024-03-22	15,000	$129.49	15,130	No	4	M	Direct
Common Stock	Disposition	2024-03-22	1,780	$234.62	13,350	No	4	S	Direct
Common Stock	Disposition	2024-03-22	735	$235.34	12,615	No	4	S	Direct
Common Stock	Disposition	2024-03-22	3,612	$236.62	9,003	No	4	S	Direct
Common Stock	Disposition	2024-03-22	5,212	$237.56	3,791	No	4	S	Direct
Common Stock	Disposition	2024-03-22	3,661	$238.29	130	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2024-03-21	15,000	$0.00	15,000	$129.49
Common Stock	Stock Options	Disposition	2024-03-22	15,000	$0.00	15,000	$129.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
521,654	2014-12-31	2024-12-31	No	4	M	Direct
506,654	2014-12-31	2024-12-31	No	4	M	Direct

Footnotes

This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
This transaction was executed in multiple trades at prices ranging from $234.03 to $235.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $235.07 to $236.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $236.085 to $237.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $237.10 to $237.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $234.02 to $235.015. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $235.02 to $235.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $236.09 to $237.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $237.15 to $238.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $238.01 to $238.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.